Zakia Belhadj

608 citations
10 papers · 492 indexed · h-index 7
Topics
Nanoplatforms for cancer theranostics (4 papers)Nanoparticle-Based Drug Delivery (3 papers)Extracellular vesicles in disease (3 papers)
Journals
SHILAP Revista de lepidopterologíaJournal of Controlled ReleaseOncotarget
Partner nations
ChinaUnited States

In The Last Decade

Zakia Belhadj

10 papers receiving 485 citations

Peers

Zakia Belhadj
Comparison fields: 5 of 70
  • Molecular Biology 285
  • Biomaterials 164
  • Biomedical Engineering 161
  • Cancer Research 89
  • Immunology 78
Replace Xinchun Xu with:
Xinchun Xu China
Siyang Song China
Jilian R. Melamed United States
Sukyung Song South Korea
Luke van der Koog Netherlands
Eriya Kenjo Japan
Rayhaneh Afjei United States
Ayşe Gülten Kantarcı Türkiye
Collin T. Inglut United States
Feifei Yang China
Zakia Belhadj relative to Xinchun Xu China Xinchun Xu's profile →
Citations per field
00.5×1.5×
Xinchun Xu · 1×
Citations per year

Countries citing papers authored by Zakia Belhadj

Since Specialization
Citations

This map shows the geographic impact of Zakia Belhadj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zakia Belhadj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zakia Belhadj more than expected).

Fields of papers citing papers by Zakia Belhadj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zakia Belhadj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zakia Belhadj. The network helps show where Zakia Belhadj may publish in the future.

Co-authorship network of co-authors of Zakia Belhadj

This figure shows the co-authorship network connecting the top 25 collaborators of Zakia Belhadj. A scholar is included among the top collaborators of Zakia Belhadj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zakia Belhadj. Zakia Belhadj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 3
2 48
3 3
4 1
5 14
6 102
7 14
8 165
9 78
10 64

About Zakia Belhadj

Zakia Belhadj is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology, having authored 10 papers that have together received 492 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Biomaterials (164 citations), Pharmaceutical Science (60 citations) and Cancer Research (89 citations). Zakia Belhadj has collaborated with scholars based in China and United States. Frequent co-authors include Bing He, Xueqing Wang, Wenbing Dai, Qiang Zhang, Hua Zhang, Hailiang Deng, Siyang Song, Qiang Zhang, Yujie Shi and Xiaoli Wei. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026